Search results
Results From The WOW.Com Content Network
Shares of Cytokinetics with a market capitalization of over $9 billion, as of Friday's closing price, have more than tripled in value since Oct. 31, when reports of the company attracting takeover ...
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.
Shares of the San Francisco-based Cytokinetics surged over 80% to touch a more than a 19-year high of $83.82, on track to add as much as $3.74 bi Cytokinetics heart drug succeeds in closely ...
On Monday, Reuters reported that Novartis is in the lead to acquire Cytokinetics, ahead of other bidders that include AstraZeneca and Johnson & Johnson. Novartis drops pursuit of Cytokinetics - source
Companies that listed their shares on the Nasdaq stock exchange, including the eponymous company ... Scholastic Corporation (6 C, 20 P, 1 F) T. Tucows (6 P) V.
James A. Spudich ( / ˈspʊdɪtʃ / [1]) is an American scientist and professor. He is the Douglass M. and Nola Leishman Professor of Biochemistry and of Cardiovascular Disease at Stanford University and works on the molecular basis of muscle contraction. He was awarded the Albert Lasker Basic Medical Research Award in 2012 with Michael Sheetz ...
Investing in biotechs is not for the faint of heart. Case in point: Cytokinetics (CYTK) shares cratered over 40% following the release of disappointing clinical trial results.Specifically, in the ...
Cytokine. Cytokines are a broad and loose category of small proteins (~5–25 kDa [1]) important in cell signaling. Due to their size, cytokines cannot cross the lipid bilayer of cells to enter the cytoplasm and therefore typically exert their functions by interacting with specific cytokine receptors on the target cell surface.